Investigating Potential Biomarkers in Autism Spectrum Disorder

Area of Science:

• Neuroscience
• Biochemistry
• Genetics

Background:

• Early identification and treatment of autism spectrum disorder (ASD) are crucial for improving outcomes.
• A lack of specific evidence hinders individualized treatment recommendations for ASD.
• Biomarkers measurable in clinical settings could revolutionize ASD patient care.

Purpose of the Study:

• To demonstrate the feasibility of collecting biomarker data during routine autism specialty clinical visits.
• To explore the relationship between various biomarkers and clinical symptoms in ASD.
• To investigate potential biochemical and clinical associations in a pediatric ASD cohort.

Main Methods:

• Eighty-three children (aged 5-10 years) with ASD participated in a multi-site feasibility study.
• Biochemical (blood serotonin, urine melatonin sulfate) and clinical (head circumference, dysmorphology, digit ratio, cognitive, behavioral) biomarkers were collected.
• Data analysis involved Wilcoxon two-sample tests and Spearman correlations.

Main Results:

• Participants were predominantly male (82%) and White (63%), with diverse functioning levels.
• Group means indicated hyperserotonemia; higher income correlated with increased blood serotonin and urine melatonin sulfate excretion.
• Melatonin levels negatively correlated with age and neurologic problems; dysmorphic status correlated with stereotyped behavior and inappropriate speech.

Conclusions:

• This project successfully collected multiple biomarkers, enabling examination of biochemical and clinical measure associations.
• Findings suggest directions for future research, including links between socioeconomic factors and specific biomarkers.
• The proposed clinical research model shows potential for integrative biomarker research in complex neurodevelopmental disorders like ASD.